Met Life Investment Management, LLC Pmv Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

$18 Billion
Q4 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Apr 29, 2024	BUY	$3.94 - $6.27 $87,247 - $138,842	22,144 New	22,144 $138,000
Q2 2023 Aug 10, 2023	BUY	$3.94 - $6.27 $87,247 - $138,842	22,144 New	22,144 $138,000
Q1 2023 May 09, 2024	BUY	$4.77 - $9.16 $105,626 - $202,839	22,144 New	22,144 $106 Million
Q4 2022 Jun 14, 2023	BUY	$8.17 - $12.95 $180,916 - $286,764	22,144 New	22,144 $192,000
Q3 2022 May 10, 2024	BUY	$11.4 - $17.18 $30,050 - $45,286	2,636 Added 13.51%	22,144 $263,000
Q3 2022 Jun 14, 2023	BUY	$11.4 - $17.18 $252,441 - $380,433	22,144 New	22,144 $263,000
Q3 2022 Mar 22, 2023	BUY	$11.4 - $17.18 $30,050 - $45,286	2,636 Added 13.51%	22,144 $263,000
Q3 2022 Nov 14, 2022	BUY	$11.4 - $17.18 $30,050 - $45,286	2,636 Added 13.51%	22,144 $264,000
Q2 2022 May 10, 2024	BUY	$9.23 - $22.43 $24,828 - $60,336	2,690 Added 15.99%	19,508 $277,000
Q2 2022 Jun 20, 2023	BUY	$9.23 - $22.43 $180,058 - $437,564	19,508 New	19,508 $277,000
Q2 2022 Mar 22, 2023	BUY	$9.23 - $22.43 $24,828 - $60,336	2,690 Added 15.99%	19,508 $277,000
Q2 2022 Aug 11, 2022	BUY	$9.23 - $22.43 $24,828 - $60,336	2,690 Added 15.99%	19,508 $278,000
Q1 2022 May 10, 2024	BUY	$14.86 - $23.55 $249,915 - $396,063	16,818 New	16,818 $350,000
Q1 2022 Jun 20, 2023	BUY	$14.86 - $23.55 $249,915 - $396,063	16,818 New	16,818 $350,000
Q1 2022 Mar 22, 2023	BUY	$14.86 - $23.55 $92,236 - $146,174	6,207 Added 58.5%	16,818 $350,000
Q1 2022 May 12, 2022	BUY	$14.86 - $23.55 $92,236 - $146,174	6,207 Added 58.5%	16,818 $350,000
Q4 2021 Jun 21, 2023	BUY	$19.99 - $30.24 $212,113 - $320,876	10,611 New	10,611 $245,000
Q3 2021 Jun 21, 2023	BUY	$26.84 - $36.58 $284,799 - $388,150	10,611 New	10,611 $316,000
Q2 2021 May 17, 2024	SELL	$28.01 - $36.01 $308,474 - $396,578	-11,013 Reduced 50.93%	10,611 $362,000
Q2 2021 Mar 22, 2023	SELL	$28.01 - $36.01 $308,474 - $396,578	-11,013 Reduced 50.93%	10,611 $362,000
Q2 2021 Aug 16, 2021	SELL	$28.01 - $36.01 $308,474 - $396,578	-11,013 Reduced 50.93%	10,611 $362,000
Q1 2021 May 17, 2024	BUY	$30.66 - $49.5 $662,991 - $1.07 Million	21,624 New	21,624 $711,000
Q1 2021 Jun 26, 2023	BUY	$30.66 - $49.5 $662,991 - $1.07 Million	21,624 New	21,624 $711 Million
Q1 2021 Mar 22, 2023	BUY	$30.66 - $49.5 $471,704 - $761,557	15,385 Added 246.59%	21,624 $711,000
Q1 2021 May 14, 2021	BUY	$30.66 - $49.5 $471,704 - $761,557	15,385 Added 246.59%	21,624 $711,000
Q4 2020 May 24, 2024	BUY	$31.86 - $61.51 $198,774 - $383,760	6,239 New	6,239 $383,000
Q4 2020 Jun 22, 2023	BUY	$31.86 - $61.51 $198,774 - $383,760	6,239 New	6,239 $383,000
Q4 2020 Mar 22, 2023	SELL	$31.86 - $61.51 $506,733 - $978,316	-15,905 Reduced 71.83%	6,239 $383,000
Q4 2020 Feb 16, 2021	BUY	$31.86 - $61.51 $198,774 - $383,760	6,239 New	6,239 $384,000

Others Institutions Holding PMVP

# of Institutions

Shares Held

43.2M

Call Options Held

3.1K

Put Options Held

1.7K

Orbimed Advisors LLC San Diego, CA

6.48M
Shares

$9 Million
0.26% of portfolio
Sio Capital Management, LLC New York, NY

3.57M
Shares

$4.97 Million
2.01% of portfolio
Arrow Mark Colorado Holdings LLC Denver, CO

3.51M
Shares

$4.88 Million
0.08% of portfolio
Bml Capital Management, LLC Zionsville, IN

3.47M
Shares

$4.82 Million
3.25% of portfolio
Euclidean Capital LLC New York, NY

2.63M
Shares

$3.65 Million
0.54% of portfolio

View Full List

About PMV Pharmaceuticals, Inc.

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $63.4M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

More about PMVP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account